
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.
Saturday, 21 November 2026
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.